| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/31/2006 | US7129063 Junction-enriched and -associated protein (JEAP); antibodies for visualizing localization |
| 10/31/2006 | US7129061 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand or "TRELL", a polypeptide which is a member of the Tumor Necrosis Factor Family |
| 10/31/2006 | US7129060 Export systems for recombinant proteins |
| 10/31/2006 | US7129058 Method of production of a nanoparticle of a compound semiconductor in a cavity of protein |
| 10/31/2006 | US7129055 Detection of translocation protein in sample; obtain tissue sample, incubate with binding agent, detect binding activity, presence of bound agent indicates presence of translocation protein |
| 10/31/2006 | US7129053 Immuno-chromatographic rapid assay in order to detect acid-resistant microorganisms in the stool |
| 10/31/2006 | US7129040 identification, on human chromosome 10, of a tumor suppressor gene. Defects in this gene are associated with the development of cancers, such as gliomas |
| 10/31/2006 | US7129039 Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
| 10/31/2006 | US7128920 Isolated polypeptide and polynucleotide of given sequence; diagnosing or prognosing a disease by determining the presence or absence of a mutation in gene; Streptococcus pneumoniae |
| 10/31/2006 | US7128919 Comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides |
| 10/31/2006 | US7128917 Expression vector coding viral peptides for use in generating vaccine for prevention of viral diseases in fish hatcheries; aquaculture and fish farming |
| 10/31/2006 | US7128915 Membrane virus host range mutations and their uses as vaccine substrates |
| 10/31/2006 | US7128913 Erythropoietin conjugates |
| 10/31/2006 | US7128912 Fibronectin binding protein compositions and methods of use |
| 10/31/2006 | US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide |
| 10/31/2006 | US7128910 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof |
| 10/31/2006 | US7128908 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof |
| 10/31/2006 | US7128907 Methods of treating crohn's disease with anti-TNF antibodies |
| 10/31/2006 | US7128906 T1 receptor-like ligand II and uses thereof |
| 10/31/2006 | US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated. |
| 10/31/2006 | US7128875 Signal processing devices comprising biological and bio-mimetic components |
| 10/31/2006 | CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 10/31/2006 | CA2250047C Monoclonal antibodies binding human growth hormone (hgh) |
| 10/31/2006 | CA2212649C Hydrolyzed collagen type ii and use thereof |
| 10/31/2006 | CA2162677C Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 10/31/2006 | CA2129733C Mammalian expression systems for hcv proteins |
| 10/26/2006 | WO2006113907A2 Escherichia coli o157:h7 proteins and uses thereof |
| 10/26/2006 | WO2006113861A2 Mammalian expression systems |
| 10/26/2006 | WO2006113782A2 Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof |
| 10/26/2006 | WO2006113767A2 Hgf beta chain variants |
| 10/26/2006 | WO2006113559A2 Methods for modulating bone formation and mineralization by modulating krc activity |
| 10/26/2006 | WO2006113522A2 Methods of detecting hepatitis c virus |
| 10/26/2006 | WO2006113487A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 10/26/2006 | WO2006113402A1 Methods and compositions for modulating and detecting wisp activity |
| 10/26/2006 | WO2006113372A2 Porcine circovirus and helicobacter combination vaccines |
| 10/26/2006 | WO2006113331A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists |
| 10/26/2006 | WO2006113277A2 Multivalent soluble tyrokinase receptor that bind angiogenic factor |
| 10/26/2006 | WO2006113214A2 Vaccine against pandemic strains of influenza viruses |
| 10/26/2006 | WO2006112962A2 Syphilis diagnostic test and kits |
| 10/26/2006 | WO2006112930A2 Q3 sparc deletion mutant and uses thereof |
| 10/26/2006 | WO2006112929A2 The hiv gp-41-membrane proximal region arrayed on hepatitis b surface antigen particles as novel antigens |
| 10/26/2006 | WO2006112925A2 Cxcr3 is a gliadin receptor |
| 10/26/2006 | WO2006112739A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 10/26/2006 | WO2006112738A1 Novel peptides and methods for the treatment of inflammatory disorders |
| 10/26/2006 | WO2006112737A1 Vesiculins |
| 10/26/2006 | WO2006112551A2 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 10/26/2006 | WO2006112550A2 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 10/26/2006 | WO2006112451A1 Anti-cancer agent comprising protein c inhibitor |
| 10/26/2006 | WO2006112327A1 Lk3 gene regulating rice grain length and the use thereof |
| 10/26/2006 | WO2006112238A1 Gene capable of controlling differentiation/growth of plant, and use of the same |
| 10/26/2006 | WO2006112040A1 NOVEL β-GALACOTSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD OF PRODUCING THE SAME |
| 10/26/2006 | WO2006112025A1 NOVEL β-GALACTOSIDE-α-2,3-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD FOR PRODUCING THE SAME |
| 10/26/2006 | WO2006111946A2 Toll-like receptor 14 (tlr14 ) and use thereof |
| 10/26/2006 | WO2006111745A2 Composition and method for treating viral infection |
| 10/26/2006 | WO2006111743A2 Identifying lantibiotic gene clusters and novel lantibiotic genes |
| 10/26/2006 | WO2006111616A1 Peptide vaccine for influenza virus |
| 10/26/2006 | WO2006111060A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta |
| 10/26/2006 | WO2006087340A3 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor |
| 10/26/2006 | WO2006084714A9 Novel gene sts 18 |
| 10/26/2006 | WO2006083984A9 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 10/26/2006 | WO2006077152A3 Hla fusion molecules and uses thereof |
| 10/26/2006 | WO2006077126A3 Cx3cr1 as a marker which correlates with both disease and disease activity in multiple sclerosis patients |
| 10/26/2006 | WO2006077035A9 Peptides with neuropeptide-2 receptor (y2r) agonist activity |
| 10/26/2006 | WO2006069306A3 A knockout mouse for the tumor suppressor gene anx7 |
| 10/26/2006 | WO2006058539A3 Growth hormone secretagogue receptor 1a ligands |
| 10/26/2006 | WO2006055331A9 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 10/26/2006 | WO2006044840A3 Soluble zcytor21, anti-zcytor21 antibodies and binding partners and methods of using in inflammation |
| 10/26/2006 | WO2006008660A3 Streptococcus pneumoniae enoyl- (acyl-carrier-protein) reductase (fabk) |
| 10/26/2006 | WO2006005589A3 Polypeptide species useful for the treatment of neurological disorders |
| 10/26/2006 | WO2005095625A8 Arabinogalactan protein compositions and methods for fostering somatic embryogenic competence |
| 10/26/2006 | WO2005079840A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 10/26/2006 | WO2005060542A3 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 10/26/2006 | WO2004078995A3 Methods of modulating and of identifying agents that modulate intracellular calcium |
| 10/26/2006 | WO2004063153A3 Low efficacy gonadotropin agonists and antagonists |
| 10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
| 10/26/2006 | WO2002078420A3 Molecules for disease detection and treatment |
| 10/26/2006 | US20060242738 Polynucleotides and polypeptides in plants |
| 10/26/2006 | US20060242737 Modulation of flowering time by the pft1 locus |
| 10/26/2006 | US20060242733 transformed plant comprising in its genome a stably incorporated nucleotide construct containing a nucleotide sequence that encodes a polypeptide that is pesticidal for pest belonging to the order Lepidoptera, coding sequence is operably linked to a promoter that drive expression in a plant cell |
| 10/26/2006 | US20060242732 encode pesticidal proteins; transgenic pest resistant plants |
| 10/26/2006 | US20060242724 Receptor |
| 10/26/2006 | US20060242723 Chimeric mouse with regulated bradeion gene expression |
| 10/26/2006 | US20060242721 Gene families associated with liver cancer |
| 10/26/2006 | US20060242720 Inducible site-directed mutagenesis through conditional gene rescue |
| 10/26/2006 | US20060242718 SOCS-box containing peptides |
| 10/26/2006 | US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof |
| 10/26/2006 | US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis |
| 10/26/2006 | US20060241290 recombinant or monoclonal antibodies comprising the antigen-binding fragments specific for polypeptides, used for treating the effects of stroke, hypoxia and/or ischemia |
| 10/26/2006 | US20060241287 Extracting biopolymers from a biomass using ionic liquids |
| 10/26/2006 | US20060241286 Novel peptides and the application thereof in therapy |
| 10/26/2006 | US20060241285 Crystals and structure of Synagis Fab |
| 10/26/2006 | US20060241284 Transmembrane protein amigo and uses thereof |
| 10/26/2006 | US20060241282 synthesis of long peptides (over 20 amino acid residues) or for peptides where synthesis is problematic on 2-chlorotritylchloride resin; first resin is chosen so that it does not lead to the formation of cyclic dipeptides and in particular to the formation of diketopiperazine compounds |
| 10/26/2006 | US20060241103 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope |
| 10/26/2006 | US20060241068 Cardiac failure, cardiomegaly, myocarditis, cardiomyopathy, arteriosclerosis, arteriosclerosis obliterans, or ischemic heart disease |
| 10/26/2006 | US20060241053 Compounds and their analgesic applications |
| 10/26/2006 | US20060241051 Metastin derivatives and use thereof |
| 10/26/2006 | US20060241047 FSH or a FSH variant containing an alpha and beta subunit contained in formulations, and articles of manufacture. The invention provides advantageous new proteins and nucleic acids, multi-use pharmaceutical solutions, formulations and |
| 10/26/2006 | US20060241046 Peptide for use in the treatment of parasitic, brain, nervous system, psychological and viral disorders |
| 10/26/2006 | US20060241045 Method for producing preparation containing bioactive substance |